Search Results
Found 1 results
510(k) Data Aggregation
(58 days)
AUTOSTAT II ANTI-GLIADIN IGG ELISA
Enzyme linked immunosorbent assay method for the semi-quantitative determination of specific IgG autoantibodies to gliadin in human serum.
Uses:
The results of the anti-gliadin IgG assay can be used as an aid in the diagnosis of diseases associated with elevated levels of anti-gliadin antibodies including Coeliac Disease.
Levels of these antibodies are one indicator in a multi-factorial diagnostic regime.
The assay may be used on the Hycor Hy•Tec Automated EIA instrument.
For in vitro diagnostic use only.
Not Found
This FDA communication is a clearance letter for a medical device (Autostat™ II Anti-Gliadin IgG ELISA). It indicates that the device has been reviewed and found to be "substantially equivalent" to legally marketed predicate devices. However, the document does not contain the acceptance criteria for the device's performance, nor does it detail the study that proves the device meets those criteria.
Therefore, I cannot extract the requested information from this document. The letter focuses on regulatory approval based on equivalence rather than presenting performance data or study specifics.
Ask a specific question about this device
Page 1 of 1